17h
Everyday Health on MSN4 Ways Polycythemia Vera Can Affect Your Quality of Life — and What You Can Do About ItJust like any chronic health condition, polycythemia vera (PV) can have a negative impact on your everyday life. Research has ...
6h
KSNW Wichita on MSNNewton comes together for teen with blood cancerBethel College athletes hosted a cheek swab drive Wednesday and continued Thursday evening. It’s all to find a bone marrow ...
Genomic Interrogation of Secondary-Type Acute Myeloid Leukemia: Response and Outcomes to Contemporary Therapies,” published in the February 2025 issue of American Journal of Hematology by Senapati et ...
8h
GlobalData on MSNTC BioPharm completes dosing in Cohort A of Phase IIb trial for AMLThe trial was designed to evaluate the therapy’s efficacy and safety in treating AML, as well as myelodysplastic syndromes.
The FDA accepted Regeneron’s BLA resubmission for linvoseltamab in relapsed or refractory multiple myeloma, with a decision ...
The firm will offer up to 12,030,218 common shares for Keystone Capital Partners to sell and is expecting to net around $2.1 million in gross proceeds.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results